Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375843 · ClinicalTrials.gov registry record · Phase 4
Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication
A Phase 4 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Phase 4
- Development phase
- 118
- Enrollment target
NCT00375843: Completed Phase 4 study, sponsored by National Institute of Mental Health (NIMH).
NCT00375843 is a Phase 4 study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 118 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00375843, a Phase 4 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 118 participants
- Enrollment target
Study Summary
This study will examine how brain activity is affected by antidepressant treatment and how changes in brain activity relate to treatment response in people with depression.
Interventions
- DRUG Escitalopram
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
What the finished NCT00375843 record still lists
NCT00375843 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Escitalopram is the first listed.
NCT00375843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00375843 about?
NCT00375843 is a clinical study titled "Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication". This study will examine how brain activity is affected by antidepressant treatment and how changes in brain activity relate to treatment response in people with depression.
What is the current status of trial NCT00375843?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 118 participants. The study started on 2005-01. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00375843?
The interventions under investigation include: Escitalopram (DRUG), Sertraline (DRUG).
Who is sponsoring clinical trial NCT00375843?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00375843's enrollment target sits among peer trials
118 713th of 2000 higher than 1,287 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia